ZTS Zoetis Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZTS

Price (delayed)

$209.58

Market cap

$99.33B

P/E Ratio

52.13

Dividend/share

$0.95

EPS

$4.02

Enterprise value

$103.01B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
ZTS's equity is up by 46% year-on-year and by 6% since the previous quarter
Zoetis's EPS has increased by 18% YoY and by 8% QoQ
The P/E is 35% higher than the 5-year quarterly average of 38.7 and 13% higher than the last 4 quarters average of 46.0
Zoetis's quick ratio has decreased by 3.3% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.zoetis.com/
Peers: LLY MRK PFE HSKA

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
473.94M
Market cap
$99.33B
Enterprise value
$103.01B
Valuations
Price to earnings (P/E)
52.13
Price to book (P/B)
22.87
Price to sales (P/S)
13.43
EV/EBIT
39.97
EV/EBITDA
34.13
EV/Sales
13.9
Earnings
Revenue
$7.41B
EBIT
$2.58B
EBITDA
$3.02B
Free cash flow
$1.7B
Per share
EPS
$4.02
Free cash flow per share
$3.58
Book value per share
$9.16
Revenue per share
$15.61
TBVPS
$20.45
Balance sheet
Total assets
$14.07B
Total liabilities
$9.72B
Debt
$7.34B
Equity
$4.35B
Working capital
$4.96B
Liquidity
Debt to equity
1.69
Current ratio
3.37
Quick ratio
2.31
Net debt/EBITDA
1.22
Margins
EBITDA margin
40.7%
Gross margin
69.5%
Net margin
25.8%
Operating margin
34.7%
Efficiency
Return on assets
13.8%
Return on equity
48.3%
Return on invested capital
23.3%
Return on capital employed
21.5%
Return on sales
34.8%
Dividend
Dividend yield
0.45%
DPS
$0.95
Payout ratio
23.6%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
-0.45%
1 week
1.58%
1 month
5.96%
1 year
29%
YTD
26.63%
QTD
7.95%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$7.41B
Gross profit
$5.15B
Operating income
$2.57B
Net income
$1.91B
Gross margin
69.5%
Net margin
25.8%
Zoetis's operating income has increased by 19% YoY and by 6% QoQ
The net income has grown by 18% YoY and by 8% from the previous quarter
ZTS's revenue is up by 17% YoY and by 6% QoQ
The gross profit has grown by 16% YoY and by 6% from the previous quarter

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
P/E
52.13
P/B
22.87
P/S
13.43
EV/EBIT
39.97
EV/EBITDA
34.13
EV/Sales
13.9
The P/E is 35% higher than the 5-year quarterly average of 38.7 and 13% higher than the last 4 quarters average of 46.0
Zoetis's EPS has increased by 18% YoY and by 8% QoQ
ZTS's equity is up by 46% year-on-year and by 6% since the previous quarter
The stock's price to book (P/B) is 14% more than its 5-year quarterly average of 20.1 and 13% more than its last 4 quarters average of 20.3
ZTS's price to sales (P/S) is 58% higher than its 5-year quarterly average of 8.5 and 16% higher than its last 4 quarters average of 11.6
ZTS's revenue is up by 17% YoY and by 6% QoQ

Efficiency

How efficient is Zoetis business performance
The company's return on equity fell by 17% YoY
ZTS's ROIC is up by 13% YoY and by 6% QoQ
ZTS's return on assets is up by 5% since the previous quarter

Dividends

What is ZTS's dividend history
Dividend details
DPS
$0.95
Dividend yield
0.45%
Payout ratio
23.6%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 45% greater than its total liabilities
ZTS's total assets is up by 8% year-on-year
The total liabilities has decreased by 3.6% YoY
The debt is 69% higher than the equity
ZTS's equity is up by 46% year-on-year and by 6% since the previous quarter
Zoetis's debt to equity has decreased by 36% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.